142 related articles for article (PubMed ID: 3023584)
1. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
[TBL] [Abstract][Full Text] [Related]
2. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
Harris DT; Hale AH; Lefrancois L
J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
[TBL] [Abstract][Full Text] [Related]
3. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
[TBL] [Abstract][Full Text] [Related]
4. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
Dargan DJ; Galt CB; Subak-Sharpe JH
J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
Sabina LR; Telasco CE
Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
[TBL] [Abstract][Full Text] [Related]
6. Interferon treatment inhibits glycosylation of a viral protein.
Maheshwari RK; Banerjee DK; Waechter CJ; Olden K; Friedman RM
Nature; 1980 Oct; 287(5781):454-6. PubMed ID: 6159539
[TBL] [Abstract][Full Text] [Related]
7. Low infectivity of vesicular stomatitis virus (VSV) particles released from interferon-treated cells is related to glycoprotein deficiency.
Maheshwari RK; Husain MM; Friedman RM
Biochem Biophys Res Commun; 1983 Nov; 117(1):161-8. PubMed ID: 6318745
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of the production of infectious particles in cells infected with Junín virus in the presence of tunicamycin].
Daelli MG; Coto CE
Rev Argent Microbiol; 1982; 14(3):171-6. PubMed ID: 6101002
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles.
Dalton KP; Rose JK
Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797
[TBL] [Abstract][Full Text] [Related]
10. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
Fredericksen BL; Whitt MA
Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
[TBL] [Abstract][Full Text] [Related]
12. Assembly of viral membranes: maturation of the vesicular stomatitis virus glycoprotein in the presence of tunicamycin.
Morrison TG; McQuain CO; Simpson D
J Virol; 1978 Oct; 28(1):368-74. PubMed ID: 212608
[TBL] [Abstract][Full Text] [Related]
13. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and infectivity of vesicular stomatitis virus containing nonglycosylated G protein.
Gibson R; Leavitt R; Kornfeld S; Schlesinger S
Cell; 1978 Apr; 13(4):671-9. PubMed ID: 207437
[TBL] [Abstract][Full Text] [Related]
15. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
16. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
Závadová Z; Závada J
Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
[TBL] [Abstract][Full Text] [Related]
17. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
Maheshwari RK; Friedman RM
J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
[TBL] [Abstract][Full Text] [Related]
18. Double-layered membrane vesicles released from mammalian cells infected with Sendai virus expressing the matrix protein of vesicular stomatitis virus.
Sakaguchi T; Uchiyama T; Fujii Y; Kiyotani K; Kato A; Nagai Y; Kawai A; Yoshida T
Virology; 1999 Oct; 263(1):230-43. PubMed ID: 10544097
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopic observations of vesicular stomatitis virus particles penetration in human fibroblasts.
Cernescu C; Constantinescu SN; Popescu LM
Rev Roum Virol; 1990; 41(2):93-6. PubMed ID: 2176536
[TBL] [Abstract][Full Text] [Related]
20. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
Maheshwari RK; Friedman RM
Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
